Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Proposed IND Study For ‘Abuse Potential’ Could Close US Kratom Supplement Market

Aug 09 2021

• By Malcolm Spicer

• Source: Alamy

Related Content

US HHS Pulled Recommendation To Make Kratom A Controlled Substance, But Kept Mum On Change

Jan 29 2021

Another Notice For Comments On Kratom: Cue Second Wave Of Support For Botanical In US?

Jul 22 2021

With Seizure in Florida, FDA Targets Kratom As Unsafe For Any Use

May 25 2021

FDA Turns Kratom's Future In US Dietary Supplement Market Into History

Nov 15 2017

Additional Topics

International United States US States Dietary Supplements FDA Enforcement Advertising, Marketing & Sales Commercial Consumer Drug Approval Standards Ingredients Policy Politics Regulation

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window